ALBANY, N.Y., April 20, 2021 /PRNewswire/ -- The increase in the number of bleeding disorders across the globe has been alarming in recent years. A change in lifestyle habits and other factors have ...
Researchers at Baylor College of Medicine are recommending that all COVID-19 patients admitted to the ICU undergo a thromboelastography (TEG) to test for the risk of forming blood clots. This ...
The diagnostics advisory committee reviewed the evidence available on the cost effectiveness of viscoelastometric testing to help detect, manage and monitor haemostasis in cardiac surgery and in the ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 causes not only hypercoagulability, but also "fibrinolysis shutdown," which is associated ...
The TEG6S is a novel haemostasis analyser utilising resonance technology. It offers potentially greater coagulation information and ease of use, however has not been independently validated in a ...
BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...
Researchers at Baylor College of Medicine are recommending that all COVID-19 patients admitted to the ICU undergo a thromboelastography (TEG) to test for the risk of forming blood clots. This ...
- The global point-of-care coagulation testing devices market is extrapolated to expand at a CAGR of ~6 percent between 2019 and 2027 ALBANY, N.Y., April 20, 2021 /PRNewswire/ -- The increase in the ...
The National Institute for Health and Care Excellence (NICE) is producing guidance on using viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems) in the NHS in England. The ...
Researchers at Baylor College of Medicine are recommending that all COVID-19 patients admitted to the ICU undergo a thromboelastography (TEG) to test for the risk of forming blood clots. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results